Effect of l-Threo-3,4-dihydroxyphenylserine chronic administration on cerebrospinal fluid and plasma free 3-methoxy-4-hydroxy-phenylglycol concentration in patients with Parkinson's disease
- 1 March 1986
- journal article
- research article
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 73 (1) , 39-44
- https://doi.org/10.1016/0022-510x(86)90061-4
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Effective Treatment of Pure Akinesia with L-threo-3,4-Dihydroxyphenylserine (DOPS)Clinical Neuropharmacology, 1985
- Treatment of parkinsonism with L‐thereo‐3, 4‐dihydroxyphenylserineNeurology, 1984
- Plasma and cerebrospinal fluid 3-methoxy-4-hydroxyphenylethylene glycol (MHPG) as indices of brain norepinephrine metabolism in primatesBrain Research, 1982
- Analysis of urinary 4-hydroxy-3-methoxyphenylethylene glycol as vanillyl alcohol by high-performance liquid chromatography with amperometric detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1979
- Significance of central noradrenergic system on harmaline induced tremorPharmacology Biochemistry and Behavior, 1979
- Decarboxylation of stereoisomers of 3, 4-dihydroxyphenylserine (DOPS) in vitroFolia Pharmacologica Japonica, 1976
- INHIBITORY EFFECT OF (+)THREO-3,4-DIHYDROXY-PHENYLSERINE (DOPS) ON DECARBOXYLATION OF (−)THREO-DOPSThe Japanese Journal of Pharmacology, 1976
- (S)-norepinephrine in the tissues of mice and rats given racemic erythro-3, 4-dihydroxyphenylserine (DOPS)Life Sciences, 1972
- Aromatic l-Amino Acid DecarboxylaseJournal of Biological Chemistry, 1962